| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride |
| Available forms, composition and doses of Izofran Zydis: |
| Tablets; Buccal, Oral; Ondansetron Hydrochloride 4 mgTablets; Buccal, Oral; Ondansetron Hydrochloride 8 mg |
| Izofran Zydis medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Emnil | Ondansetron Hydrochloride | Vilberry Healthcare |
| Entron | Ondansetron Hydrochloride | Ethica Industri Farmasi |
| Fixca | Ondansetron Hydrochloride | Grupo Vita / Vita Cientifica |
| Helmine | Ondansetron Hydrochloride | GlaxoSmithKline |
| Izofran | Ondansetron Hydrochloride | GlaxoSmithKline |
| Jamp-Ondansetron | Ondansetron Hydrochloride | Jamp Pharma |
| Lametic | Ondansetron Hydrochloride | Landson |
| Mint-Ondansetron | Ondansetron Hydrochloride | Mint Pharmaceuticals |
| Modifical | Ondansetron Hydrochloride | Asofarma de Mexico; Zodiac Produtos Farmaceuticos |
| Nausedron | Ondansetron Hydrochloride | Cristalia Produtos Quimicos Farmaceuticos |